← Back to patent-cliff list
Articaine ophthalmic (American Genomics)
Tier C — Watch / tradeArticaine ophthalmic (American Genomics)
American Genomics LLC
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：SCNA
Indications (approved)：Anaesthesia
Regional status
US
Phase III
2020-09-03
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Articaine ophthalmic (American Genomics)?
Approved indications include: Anaesthesia.
When does the Articaine ophthalmic (American Genomics) patent expire?
No public expiry year is available for Articaine ophthalmic (American Genomics) yet; this page updates once verified.
How do I get a quote for Articaine ophthalmic (American Genomics) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06